ArticleJournal of general internal medicine2026
Underprescribing of Antifracture Medications Following Non-Traumatic Fracture: A Retrospective Cohort Study.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople with non-traumatic fractures typically qualify for antifracture medications to prevent recurrent fractures.
objectiveTo quantify the current osteoporosis care gap and determine factors that predict prescribing of antifracture medications following hospitalization for non-traumatic fracture.
designRetrospective cohort study.
settingTwenty hospitals from a large US health system. PATIENTS: Patients aged 50 years and older presenting to the emergency department with a non-traumatic hip, pelvic, or vertebral fracture between 2017 and 2023. MEASUREMENTS: In-hospital administration or outpatient prescription fill of antifracture medications within 180 days following hospital discharge. We estimated incident rate ratios (IRRs) using modified Poisson regression with robust standard errors to in order to determine factors associated with antifracture medication initiation.
resultsThe cohort included 9849 patients (median (IQR) age, 80 [70-87] years; 68% female) of which 9008 (91.4%) were antifracture medication naïve prior to hospital presentation. Of medication-naïve patients, 510 (5.7%) were prescribed antifracture medications, with 279 (3.1%) initiating treatment as an inpatient and 119 (1.3%) in the 180 days following discharge. Medication classes included bisphosphonate (N = 431, 85%), RANK ligand inhibitors and selective estrogen receptor modulators (N = 56, 11%), and anabolic therapies (N = 21, 4%). Female sex (IRR 1.93; 95% CI 1.41-2.64) and a pre-existing diagnosis of osteoporosis (IRR 1.76, 95% CI 1.47-2.11) were positively associated with medication receipt. LIMITATIONS: Inability to measure reasons for treatment non-initiation.
conclusionsThis study found very few adults with a non-traumatic fracture received medical treatment for secondary osteoporosis fracture prevention. Expanded quality improvement efforts are needed to close the osteoporosis care gap.
Identifiers
42538512What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.